Moder K G, Miller T D, Tazelaar H D
Division of Rheumatology and Internal Medicine, Mayo Clinic Rochester, MN 55905, USA.
Mayo Clin Proc. 1999 Mar;74(3):275-84. doi: 10.4065/74.3.275.
Systemic lupus erythematosus (SLE), a connective tissue disease characterized by the production of autoantibodies, can affect all organ systems. Cardiac involvement in patients with SLE has been described since the early 20th century. The manifestations are numerous and can involve all components of the heart, including the pericardium, conduction system, myocardium, valves, and coronary arteries. In recent years, echocardiography has yielded additional information about the heart in patients who have SLE with and without clinical cardiac involvement. Moreover, antiphospholipid antibodies have been linked to several cardiac manifestations in patients with SLE, including valvular abnormalities and possibly coronary artery disease. This updated, comprehensive review summarizes the new literature on SLE and the heart.
系统性红斑狼疮(SLE)是一种以自身抗体产生为特征的结缔组织病,可累及所有器官系统。自20世纪初以来,就有关于SLE患者心脏受累的描述。其表现多种多样,可累及心脏的所有组成部分,包括心包、传导系统、心肌、瓣膜和冠状动脉。近年来,超声心动图为有或无临床心脏受累的SLE患者的心脏情况提供了更多信息。此外,抗磷脂抗体与SLE患者的多种心脏表现有关,包括瓣膜异常以及可能的冠状动脉疾病。这篇更新的全面综述总结了关于SLE与心脏的新文献。